Cargando…

RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

Detalles Bibliográficos
Autores principales:	Heidenreich, Regina, Mehr, Keyvan Tadjalli, Noth, Janine, Koch, Sven, Hong, Henoch, Melber, Karl, Daehling, Angelika, Roos, Tilmann, Lutz, Johannes, Kowalczyk, Aleksandra, Baumhof, Patrick, Scheel, Birgit, Voss, Söhnke, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Gnad-Vogt, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645525/ http://dx.doi.org/10.1186/2051-1426-3-S2-P163

Ejemplares similares

A novel, disruptive vaccination technology: Self-adjuvanted RNActive(®) vaccines
por: Kallen, Karl-Josef, et al.
Publicado: (2013)

A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive(®)-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part
por: Koch, Sven D, et al.
Publicado: (2014)

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy
por: Hong, Henoch S., et al.
Publicado: (2016)

Self-adjuvanted RNActive(® )vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
por: Fotin-Mleczek, Mariola, et al.
Publicado: (2014)

Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
por: Sebastian, Martin, et al.
Publicado: (2014)

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
por: Thess, Andreas, et al.
Publicado: (2015)

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
por: Lutz, Johannes, et al.
Publicado: (2017)

A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses
por: Kallen, Karl-Josef, et al.
Publicado: (2013)

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
por: Papachristofilou, Alexandros, et al.
Publicado: (2019)

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
por: Kübler, Hubert, et al.
Publicado: (2015)

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Rauch, Susanne, et al.
Publicado: (2021)

mRNA mediates passive vaccination against infectious agents, toxins, and tumors
por: Thran, Moritz, et al.
Publicado: (2017)

Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
por: Edwards, Darin K., et al.
Publicado: (2017)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2013)

Tipps für den anästhesiologischen Arbeitsplatz
por: Boye, Söhnke, et al.
Publicado: (2010)

Immunostimulatory activity of lifespan-extending agents
por: Bravo-San Pedro, José Manuel, et al.
Publicado: (2013)

Immunostimulatory properties and antitumor activities of glucans
por: VANNUCCI, LUCA, et al.
Publicado: (2013)

Immunostimulatory Potential of Fruits and Their Extracts in Poultry
por: Hasted, Teri-Lyn, et al.
Publicado: (2021)

Structure-activity relationship of immunostimulatory effects of phthalates
por: Larsen, Søren T, et al.
Publicado: (2008)

Immunostimulatory activity of Stachys mialhesi de Noé
por: Benmebarek, Assia, et al.
Publicado: (2013)

Immunostimulatory Effects of Silica Nanoparticles in Human Monocytes
por: Yang, Eun-Jeoung, et al.
Publicado: (2013)

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
por: Nemchenko, Andriy
Publicado: (2012)

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
por: Quetglas, José I., et al.
Publicado: (2012)

Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)

The Immunostimulatory Capacity of Nontypeable Haemophilus influenzae Lipooligosaccharide
por: Gaultier, Gabrielle N., et al.
Publicado: (2017)

The immunostimulatory activity of polysaccharides from Glycyrrhiza uralensis
por: Aipire, Adila, et al.
Publicado: (2020)

Prednisolone suppresses the immunostimulatory effects of 27-hydroxycholesterol
por: Kim, Bo-Young, et al.
Publicado: (2020)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Immunostimulatory activity of soybean hull polysaccharide on macrophages
por: Wang, Mengxue, et al.
Publicado: (2022)

Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
por: Weiss, Adam M., et al.
Publicado: (2022)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs
por: Sioud, Mouldy, et al.
Publicado: (2006)

Citrullination of fibrinogen: generation of neoepitopes and enhancement of immunostimulatory properties
por: Robinson, William H, et al.
Publicado: (2012)

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

Regulation of Inflammatory Gene Expression in PBMCs by Immunostimulatory Botanicals
por: Denzler, Karen L., et al.
Publicado: (2010)

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_prihhpnsg6lt0m8dj29skg3oo1